There is strong interest in using the gut microbiome for Parkinson's disease (PD) diagnosis and treatment. However, a consensus on PD-associated microbiome features and a multi-study assessment of their diagnostic value is lacking. Here, we present a...
IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society
May 7, 2025
Dynamic brain networks are more effective than static networks in characterizing the evolving patterns of brain functional connectivity, making them a more promising tool for diagnosing neurodegenerative diseases. However, existing classification met...
AJNR. American journal of neuroradiology
May 2, 2025
BACKGROUND AND PURPOSE: The diagnostic performance of deep learning model that simultaneously detecting and quantifying nigrosome-1 abnormality by using susceptibility map-weighted imaging (SMwI) remains unexplored. This study aimed to develop and va...
In Parkinson's disease (PD), the disturbance of energy metabolism due to glucose metabolic reprogramming may be a critical factor contributing to neuronal degeneration and death. Glycolysis, as the core process of glucose metabolism, not only serves ...
Parkinson's disease ranks as the second most prevalent neurological disorder after Alzheimer's disease. Convolutional neural networks (CNNs) have been extensively employed in Parkinson's disease (PD) detection using MR images. However, CNN models gen...
Quantification of the absolute microbial abundance in a human stool sample is crucial for a comprehensive understanding of the microbial ecosystem, but this information is lost upon metagenomic sequencing. While several methods exist to measure absol...
RATIONALE AND OBJECTIVES: Diagnosing Parkinson's disease (PD) typically relies on clinical evaluations, often detecting it in advanced stages. Recently, artificial intelligence has increasingly been applied to imaging for neurodegenerative disorders....
BACKGROUND: Parkinson's disease (PD), a prevalent neurodegenerative disorder in the aging population, poses significant challenges in unraveling its pathogenesis and progression. A key area of investigation is the disruption of oncological metabolic ...
Many people suffer from Parkinson's disease globally, a complicated neurological condition caused by the deficiency of dopamine, an organic chemical responsible for regulating movement in individuals. Patients with Parkinson face muscle stiffness or ...
Parkinson's disease (PD) is a neurodegenerative disorder affecting motor control, leading to symptoms such as tremors and stiffness. Early diagnosis is essential for effective treatment, but traditional methods are often time-consuming and expensive....
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.